title: The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target.
authors.affiliation: a Director, CLL Center, Department of Medical Oncology , Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School , Boston , MA , USA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Brown
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D058990:Molecular Targeted Therapy; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2